Search research articles
Contact Us
Filters
Showing results (131-140 of 216) with videos related to
Page
of 22
Sort By:
Future Oncology (London, England)
|
July 25, 2019
Crizotinib-resistant <i>MET</i> mutations in gastric cancer patients are sensitive to type II tyrosine kinase inhibitors
Bo Shen, Feixiang Wu, Jiazhou Ye, et al.
Tissue Antigens
|
August 12, 2004
Molecular typing of human leukocyte antigen and related polymorphisms following whole genome amplification
W Shao, J Tang, M T Dorak, et al.
Biochemistry. Biokhimiia
|
February 21, 2006
Characterization and stability investigation of cu,zn-superoxide dismutase covalently modified by low molecular weight heparin
H W Zhang, F S Wang, W Shao, et al.
Genes and Immunity
|
June 23, 2006
Conserved extended haplotypes of the major histocompatibility complex: further characterization
M T Dorak, W Shao, H K G Machulla, et al.
Neuroscience
|
October 5, 2013
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein regulates neurite development via PI3K-AKT and ERK signaling pathways
C Zhou, C Li, D Li, et al.
Spinal Cord
|
October 21, 2015
EGb761 improves histological and functional recovery in rats with acute spinal cord contusion injury
M Yan, Y-w Liu, W Shao, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|
October 19, 2017
[Tumor derived IgG suppress the proliferation of T cells in cord blood]
E Y Liu, J F Liu, W W Shao, et al.
Oncology Letters
|
October 23, 2018
Genomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: A case report
Ling Peng, Zhu Zeng, Xiaodong Teng, et al.
Oncotarget
|
May 3, 2017
Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification
Juan Du, Xue Wu, Xiaoling Tong, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2018
Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas
Ying Jin, Xun Shi, Jun Zhao, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 216) with videos related to
Sort By:
Page
of 22
Future Oncology (London, England)
|
July 25, 2019
Crizotinib-resistant <i>MET</i> mutations in gastric cancer patients are sensitive to type II tyrosine kinase inhibitors
Bo Shen, Feixiang Wu, Jiazhou Ye, et al.
Tissue Antigens
|
August 12, 2004
Molecular typing of human leukocyte antigen and related polymorphisms following whole genome amplification
W Shao, J Tang, M T Dorak, et al.
Biochemistry. Biokhimiia
|
February 21, 2006
Characterization and stability investigation of cu,zn-superoxide dismutase covalently modified by low molecular weight heparin
H W Zhang, F S Wang, W Shao, et al.
Genes and Immunity
|
June 23, 2006
Conserved extended haplotypes of the major histocompatibility complex: further characterization
M T Dorak, W Shao, H K G Machulla, et al.
Neuroscience
|
October 5, 2013
BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein regulates neurite development via PI3K-AKT and ERK signaling pathways
C Zhou, C Li, D Li, et al.
Spinal Cord
|
October 21, 2015
EGb761 improves histological and functional recovery in rats with acute spinal cord contusion injury
M Yan, Y-w Liu, W Shao, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|
October 19, 2017
[Tumor derived IgG suppress the proliferation of T cells in cord blood]
E Y Liu, J F Liu, W W Shao, et al.
Oncology Letters
|
October 23, 2018
Genomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: A case report
Ling Peng, Zhu Zeng, Xiaodong Teng, et al.
Oncotarget
|
May 3, 2017
Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification
Juan Du, Xue Wu, Xiaoling Tong, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2018
Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas
Ying Jin, Xun Shi, Jun Zhao, et al.
Page
of 22